biospecimen banks

CPDR Education and Training

Research Training and Education of Urology Residents

 

Structured Research Training and Education of Urology Residents from the Walter Reed National Military Medical Center (WRNMMC) at CPDR, Department of Surgery, USU

The Urology Resident Research Training at CPDR has been a great success since its inception. Every year two residents with 3-6 months of dedicated research time receive focused and extensive research training at CPDR. Since the inception of the molecular biology laboratory in 1993, WRNMMC Urology residents have received training in Molecular Oncology using prostate cancer as the model system. The goal of this program is to provide residents:

  1. Hands on experience in the state-of-the-art molecular oncology research
  2. Knowledge and basic concepts in experimental design and data analysis
  3. Knowledge and scientific principles to improve the practice of urology

The residents spend a committed six months for their research activities. The CPDR Education and Training Program has already contributed to the training of twenty-two urology residents from WRNMMC, five international urology research fellows (Germany, Japan, India and Philippine), and one faculty member from WRNMMC. Residents are exposed to weekly presentations by CPDR researchers at the Wednesday Research Seminars. They have a weekly one hour meeting with the CPDR-Resident Research Committee which includes designated mentor(s) from the senior scientific staff of CPDR-BSRP, CPDR Scientific Director and the Residency Program Director from WRNMMC. Residents are provided with the Cancer Biology Lecture slide presentation, a 6-hour lecture delivered by Dr. Srivastava to USU Molecular and Cell Biology Program PhD students. Special experts from the prostate cancer field are invited to the CPDR on a monthly basis to address the latest findings of their research at our Wednesday Guest Speaker Seminars. Residents also are required to attend the CPDR Saturday Seminars featuring leading clinical and basic science authorities of the prostate cancer field. Urology residents receive CME credits for their participation in the Saturday meetings. The residents also participate in the biweekly Translational Research Meetings at CPDR where their expertise are merged with the multi-disciplinary team working on the translation of research findings towards clinical applications for the benefit of prostate cancer patients. The residents present their findings and receive educational criticism at the CPDR Wednesday Research Seminars. They have also been provided with the opportunity to present their findings at national or local conferences a year. The immersion of residents in intense scientific debates is an important goal of the resident research training and education program at CPDR. As a result CPDR is proud of the numerous invited presentations, special awards and travel awards that our trainees received in the past.

TRAINING OF WRAMC (NOW WRNMMC) UROLOGY RESIDENTS AT CPDR

MAJ Noah S. Schenkman, MD (1993-1994)
MAJ Michael J. Finger, MD (1994-1995)
CPT Howard B. Heidenberg, DO (1994-1995)
CPT John J. Bauer, MD (1995-1996)
MAJ G. Bennett Stackhouse, MD (1996-1997)
MAJ Robert C. Dean, MD (1997-1998)
MAJ Charles Gerry Henderson, MD (2001-2002)
CPT Trent Sterenchock, MD (2001-2002)
MAJ Stacey Koff, MD (2002-2003)
MAJ Stephen Brassell, MD (2002-2003)
CPT Thomas Novak, MD (2003-2004)
MAJ Gregory Bernstein, MD (2003-2004)
MAJ Inger Rosner (2004-2005)
CPT David Osborn (2004-2005)
CPT Eric Richter (2005-2006)
CPT Joseph Sterbis (2005-2006)
CPT Chad DeRosa (2006-2007)
CPT Kuwong Mwamukonda (2006-2007)
CPT Dorota Hawksworth (2007-2008)
CPT Eric Whitman (2007-2008)
CPT Kevin Rice (2008-2009)
CPT Timothy Nydam (2009)
CPT Patrick Parker, MD (2009-2010)
CPT George Leighton Lee, MD (2010-2011)
CPT Monika Colombo, MD (2011-2012)
CPT Philip Rosen, MD (2011-2012)
CPT James Farrel, MD (2012)
MAJ Michael Degon, MD (2013)

CURRENT EVENTS


August 21, 2014

ERG Monoclonal Antibody [9FY] Patent Issued To The Uniformed Services University Of The Health Sciences Center For Prostate Disease Research & Biocare Medical

Concord, CA – The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. has been awarded a patent in the United States (Patent No: US 8,765,916 B2) and Europe for ERG monoclonal antibodies. The patent is pending in Australia, Canada and Japan. ERG mouse antibody 9FY is a rigorously characterized antibody for its specificity of the ERG protein detection among the closely related members of the ETS transcription factor family in biological specimens.

Read Full Article

 

August 6, 2014

Genomic Health Announces Positive Topline Results of Additional, Large Independent Validation Study of Oncotype DX® Prostate Cancer Test with Multiple Clinical Endpoints

Redwood City, CA – PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced positive preliminary results from an additional independent clinical validation study conducted by the Center for Prostate Disease Research (CPDR) demonstrating that the Oncotype DX® Genomic Prostate Score (GPS) predicts multiple clinical endpoints related to disease aggressiveness in men with low- and intermediate-risk prostate cancer. This study validated the Oncotype DX prostate cancer test as a ...

Read Full Article

 

WRNMMC UsToo! Newsletter

Read the AUGUST 2014 Newsletter